会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Process for production of piperidine derivatives
    • 哌啶衍生物的制备方法
    • US06452011B1
    • 2002-09-17
    • US09634169
    • 2000-08-09
    • Thomas E. D'AmbraGarry M. Pilling
    • Thomas E. D'AmbraGarry M. Pilling
    • C07D21134
    • C07D211/54C07D211/22C07D261/04
    • The present invention relates to a method for preparing piperidine derivative compounds by converting, with a piperidine compound, regioisomers having the formula: where Z is or and where m is 1 or 4-6; Q and Y are the same or different and are selected from the group consisting of O, S, and NR5; R6 and R7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR8, SR8, and NR8R9; X3 is halogen, OR15, SR15, NR15R16, OSO2R15, or NHSO2R15; R5, R8, R9, R15, and R16 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and A is a substituent of its ring and is selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents.
    • 本发明涉及通过用哌啶化合物转化具有下式的区域异构体来制备哌啶衍生物化合物的方法:其中Z为异或其中m为1或4-6; Q和Y相同或不同,选自O,S和NR5; R6和R7相同或不同,并且选自氢,烷基部分,芳基部分,OR8,SR8和NR8R9; X3是卤素,OR15,SR15,NR15R16,OSO2R15或NHSO2R15; R5,R8,R9,R15和R16相同或不同,并且选自氢,烷基部分和芳基部分; 并且A是其环的取代基,并且选自氢,卤素,烷基,羟基,烷氧基和其它取代基。
    • 4. 发明授权
    • Process for production of piperidine derivatives
    • 哌啶衍生物的制备方法
    • US06201124B1
    • 2001-03-13
    • US08575344
    • 1995-12-21
    • Thomas E. D'AmbraGarry M. Pilling
    • Thomas E. D'AmbraGarry M. Pilling
    • C07D21134
    • C07D211/54C07D211/22C07D261/04
    • The present invention relates to a method for preparing piperidine derivative compounds by converting, with a piperidine compound, regioisomers having the formula: and where m is an integer from 1 to 6; Q and Y are the same or different and are selected from the group consisting of O, S, and NR5; G1, G2, and G3 are the same or different and are selected from the group consisting of OR8, SR8, and NR8R9; R6 and R7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR8, SR8, and NR8R9; X3 is halogen, OR15, SR15, NR15R16, OSO2R15, or NHSO2R15; R5, R8, R9, R15, and R16 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and A is a substituent of its ring and is selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents.
    • 本发明涉及通过用哌啶化合物转化具有下式的区域异构体制备哌啶衍生物化合物的方法:其中m为1至6的整数; Q和Y相同或不同,选自O,S和NR5; G1,G2和G3相同或不同,选自OR8,SR8和NR8R9; R6和R7相同或不同,并且选自氢,烷基部分,芳基部分,OR8,SR8和NR8R9; X3是卤素,OR15,SR15,NR15R16,OSO2R15或NHSO2R15; R5,R8,R9,R15和R16相同或不同,并且选自氢,烷基部分和芳基部分; 并且A是其环的取代基,并且选自氢,卤素,烷基,羟基,烷氧基和其它取代基。